SCHEMBL991101

SCHEMBL991101

Cc1ccc(N(c2ccccc2)c2ccc3c4cccc5c(N(c6ccc(C)cc6)c6ccc(C=Cc7ccccc7)cc6)ccc(c6cccc2c63)c54)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 2/20 0.42
TRPM8 Q7Z2W7 2/20 0.40
APP P05067 1/20 0.40
NFE2L2 Q16236 5/20 0.39
CTDSP1 Q9GZU7 1/20 0.38
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
CASP3 P42574 1/20 0.36
RAB9A P51151 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
PTGS2 P35354 1/20 0.36
KDR P35968 2/20 0.34
CYP1B1 Q16678 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
FGF23 Q9GZV9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26549662 1.00 RELA (0.42) RELATRPM8APPNFE2L2CTDSP1
SCHEMBL17879391 1.00 RELA (0.42) RELATRPM8APPNFE2L2CTDSP1
SCHEMBL21090037 0.99 RELA (0.44) RELATRPM8APPNFE2L2CTDSP1
SCHEMBL6775821 0.99 TRPM8 (0.41) RELATRPM8APPNFE2L2CTDSP1
SCHEMBL6297043 0.94 NFE2L2 (0.39) RELATRPM8APPNFE2L2KDM4E
SCHEMBL14099225 0.94 NFE2L2 (0.39) RELATRPM8APPNFE2L2KDM4E
SCHEMBL14099226 0.94 NFE2L2 (0.39) RELATRPM8APPNFE2L2KDM4E
SCHEMBL6770761 0.94 NFE2L2 (0.39) RELATRPM8APPNFE2L2KDM4E
SCHEMBL6772483 0.93 RELA (0.40) RELATRPM8APPNFE2L2CTDSP1
SCHEMBL14537302 0.93 NFE2L2 (0.38) RELATRPM8APPNFE2L2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133519-A1 ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES AGENCY FOR SCIENCE, TECHNOLOGY ANR RESEARCH 2010-06-03 US claimed
EP-2121573-A1 ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES Agency for Science Technology and Research (SG) 2009-11-25 EP claimed
WO-2008069756-A1 ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2008-06-12 WO claimed
US-20250169319-A1 ORGANIC LIGHT-EMITTING DISPLAY DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2025-05-22 US disclosed
US-12207516-B2 Organic light-emitting display device SAMSUNG DISPLAY CO., LTD. (KR) 2025-01-21 US disclosed
WO-2019216575-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME 서울대학교산학협력단 (KR) 2019-11-14 WO disclosed
US-10418573-B2 Organic light-emitting device comprising host, phosphorescent dopant and fluorescent dopant SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2019-09-17 US disclosed
US-20170346029-A1 ORGANIC LIGHT-EMITTING DEVICE COMPRISING HOST, PHOSPHORESCENT DOPANT AND FLUORESCENT DOPANT SAMSUNG DISPLAY CO. LTD. (KR) 2017-11-30 US disclosed
US-8518559-B2 Arylamine compounds and electronic devices AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-08-27 US disclosed
WO-2011008168-A1 ORGANIC LIGHT EMITTING MATERIALS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2011-01-20 WO disclosed
WO-2011008169-A1 ORGANIC AMBIPOLAR LIGHT EMITTING MATERIALS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2011-01-20 WO disclosed
US-20100133519-A1 ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES AGENCY FOR SCIENCE, TECHNOLOGY ANR RESEARCH 2010-06-03 US disclosed
EP-2121573-A1 ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES Agency for Science Technology and Research (SG) 2009-11-25 EP disclosed
WO-2008069756-A1 ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2008-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133519-A1 ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES TYR, AHR, ARNT RELA 2453/4885TRPM8 335/4885APP 1473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.